Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Leuven-based biopharmaceutical company, Oxurion NV, disclosed recent transparency notifications in compliance with Belgian legislation. On May 27, 2025, Atlas Special Opportunities II, LLC notified Oxurion that by May 22, 2025, its shareholding dropped to 921,914 from the total outstanding 6,156,035 shares, falling below the 15% threshold due to the sale of voting securities.

Subsequently, Oxurion received another notification on May 28, 2025, revealing that by May 27, 2025, Atlas's holding reduced to 609,382 shares, representing a fall below the 10% threshold. These notifications highlight Atlas's reduced stake in Oxurion, reflecting changes in its voting securities participation.